Logo
3ml PosiFlush SP (Sterile Fluid Path) Pack of 30

3ml PosiFlush SP (Sterile Fluid Path) Pack of 30

Becton Dickinson

Injection & infusion consumable
  • CE Marked medical device compliant with applicable European medical device legislation for sterile prefilled syringes containing 0.9% sodium chloride
  • Terminal sterilisation by moist heat in accordance with ISO 17665 (Sterilization of health care products—Moist heat) with a sterility assurance level (SAL) of 10⁻⁶
  • Biocompatibility and safety evaluated in line with ISO 10993 series (Biological evaluation of medical devices)
  • Sterility designation in accordance with EN 556 1: Requirements for medical devices to be labelled STERILE
  • Labelling and symbols aligned with EN ISO 15223 1 and EN 1041 for information supplied by the manufacturer
  • Latex Free and PVC Free as stated in BD technical data sheet and REACH Related disclosures
  • Manufactured under BD’s certified quality management systems for medical devices (e.g., ISO 13485) as referenced in BD documentation and declarations of conformity
Prefilled 0.9% sodium chloride IV flush syringe (sterile fluid path)

Description

The BD PosiFlush SP 3 mL (Sterile Fluid Path) prefilled saline syringe is a ready-to-use, single-use flushing device containing sterile 0.9% sodium chloride solution. Designed specifically for flushing indwelling vascular access devices, it eliminates the need for manual preparation of saline syringes, supporting standardised IV flushing protocols and helping reduce the risk of medication errors and catheter damage. The SP (Sterile Path) configuration provides a sterile fluid pathway for general IV flush procedures but is not intended for use on a sterile field. Each 3 mL syringe uses a standard 10 mL barrel diameter and BD Luer-Lok tip to support controlled flushing pressure and secure connection to catheters.

Bnefits

  • Ready-to-use prefilled saline syringe reduces time and steps involved in manual preparation of flush syringes, improving clinical workflow efficiency
  • Designed specifically for flushing of indwelling vascular access devices, supporting catheter patency and reducing the risk of occlusion
  • 0.9% sodium chloride solution (normal saline) provides an isotonic flush compatible with standard IV therapy practice
  • Sterile fluid path (SP) configuration suitable for general IV flush procedures without the need for needles, vials or ampoules
  • Standard 10 mL barrel diameter across 3 mL, 5 mL and 10 mL sizes helps lower the risk of catheter damage by limiting injection pressure
  • BD Luer-Lok tip provides a secure connection to IV catheters and devices, helping prevent disconnection and reflux
  • Individually packaged and barcoded syringes support traceability and inventory management
  • Terminally sterilised, preservative-free, latex-free and PVC-free design supports patient safety and compatibility with hospital policies
  • Three-year shelf life (when stored under recommended conditions) supports bulk purchasing and reduces waste

Indications

  • For flushing of indwelling vascular access devices using 0.9% sodium chloride solution
  • Flushing and maintaining patency of peripheral intravenous catheters (PIVCs)
  • Flushing and maintaining patency of peripherally inserted central catheters (PICCs) and central venous catheters (CVCs), as specified in BD PosiFlush SP/XS technical documentation and local protocols
  • Flushing and maintaining patency of implanted venous access ports, according to institutional guidelines
  • General IV flush procedures where a sterile fluid path prefilled saline syringe is appropriate
  • Use by healthcare professionals in hospitals, clinics and other clinical environments in accordance with local flushing policies

Composition

  • Sterile 0.9% sodium chloride solution (sodium chloride in water for injection), isotonic with blood
  • Sodium chloride concentration: 0.9% w/v (9 mg/mL)
  • Water for injection as diluent
  • No added preservatives
  • Syringe barrel: medical-grade polypropylene
  • Plunger stopper: elastomer (formulation qualified by BD; stopper material sterilised and compatible with 0.9% sodium chloride injection)
  • Plunger rod: plastic (polypropylene or equivalent medical-grade polymer)
  • Tip cap: compatible elastomer/plastic providing sterile closure of the fluid pathway
  • Device is latex-free and PVC-free according to BD technical data sheet

Formulation

  • Three-piece, single-use plastic syringe prefilled with 3 mL of sterile 0.9% sodium chloride solution
  • Standard 10 mL barrel outer diameter for the 3 mL configuration to help standardise flushing pressure
  • Luer-Lok tip to ensure secure, leak-resistant attachment to vascular access devices
  • Sterile fluid path (SP): solution and internal fluid pathway (barrel, stopper, tip) are sterilised; outer surface of syringe is not sterile and the device is not intended for use on a sterile field
  • Terminally sterilised by moist heat (steam autoclave) to a sterility assurance level (SAL) of 10⁻⁶
  • Preservative-free, non-pyrogenic saline solution
  • Colour-coded and clearly labelled syringe and packaging for easy product identification

Packaging

  • Unit configuration: 3 mL BD PosiFlush SP prefilled saline syringe, individually packaged
  • Box configuration: 30 prefilled syringes per shelf box (Pack of 30)
  • Shipping/case configuration: 16 boxes per shipping case (480 syringes total) for reference 306573
  • Each unit individually wrapped and barcoded to support traceability and inventory control
  • Labelling includes product name, reference (REF 306573), lot number, expiry date, sterile fluid path designation (SP), and saline concentration (0.9% NaCl)

Usage

  • For use by trained healthcare professionals only; follow institutional policies and the official Instructions for Use (IFU).
  • Intended use: flushing of in-situ vascular access devices (e.g., PIVCs, PICCs, CVCs, implanted ports) to help maintain catheter patency and reduce the risk of occlusion.
  • The syringe is for flushing only. It is not intended for reconstitution of medications, not for drug admixture, and not for direct IV medication bolus or infusion.
  • Check package integrity and expiry date before use. Do not use if the blister or syringe is damaged, if the tip cap is missing, or if the solution appears cloudy, discoloured or contains particles.
  • Remove the syringe from its packaging, maintain aseptic technique, and remove the tip cap immediately before connection to the vascular access device.
  • Expel air from the syringe as per local protocol, taking care to avoid spraying fluid; attach the Luer-Lok tip securely to the catheter hub.
  • Flush the vascular access device with an appropriate volume and technique determined by catheter type, size, medication regimen and patient characteristics, in accordance with institutional protocols.
  • Use a pulsatile (start–stop) flushing technique and positive-pressure disconnection if recommended by local guidelines to reduce reflux and maintain catheter patency.
  • Do not reuse. After single use, dispose of the syringe and any unused saline in an appropriate sharps container in accordance with local regulations.
  • BD PosiFlush SP Syringe must not be used on a sterile field; if a sterile field flush is required, use the BD PosiFlush XS (externally sterile) variant or another product specified by local protocol.

Contraindications

  • Known hypersensitivity or allergy to any component of the device or solution (e.g., sodium chloride or materials used in the syringe construction), although such reactions are rare.
  • Situations where administration of additional sodium or fluid volume is contraindicated (e.g., in certain patients with severe fluid overload or sodium-restricted states), unless the clinician has specifically assessed and accepted the risk.
  • Do not use if packaging is damaged, if sterility is compromised, or if the solution shows visible particulate matter, discolouration or cloudiness.
  • Not to be used for medication reconstitution, drug dilution, or as a primary infusion solution; it is intended for flushing only.
  • Not intended for use on a sterile field (SP configuration); for procedures requiring sterile-field presentation, an externally sterile (XS) variant or other sterile-field-appropriate product should be used.

Adverse Effects

  • When used as intended for vascular access flushing with 0.9% sodium chloride, adverse reactions are uncommon; however, potential effects may include local irritation or discomfort at the catheter site.
  • Incorrect use (e.g., excessive pressure, inappropriate syringe size or poor technique) may contribute to catheter or vessel damage; consistent barrel diameter and standardised technique are intended to mitigate this risk.
  • As with any IV flush, inadvertent extravasation or infiltration can occur if the catheter is malpositioned or dislodged.
  • Systemic adverse effects related to the small volumes of 0.9% sodium chloride used for flushing are unlikely in most patients but should be considered in those with strict sodium or fluid restrictions.
  • Any suspected adverse event or device malfunction should be managed according to institutional policy and reported through appropriate pharmacovigilance or medical device surveillance channels.

Storage Conditions

  • Store in a dry environment at controlled room temperature, typically between 15°C and 25°C, as specified in the BD PosiFlush SP/XS technical data sheet.
  • Keep syringes in their original packaging until point of use to protect from contamination, moisture and strong light.
  • Do not freeze. Avoid exposing the product to excessive heat or direct sunlight.
  • Observe the labelled expiry date; BD PosiFlush syringes typically have a 3-year shelf life when stored under recommended conditions.
  • Rotate stock using first-expiry-first-out (FEFO) principles in line with institutional procedures.

Duration

Not applicable; BD PosiFlush SP 3 mL syringes are single-use flushing devices employed episodically according to vascular access maintenance protocols rather than for defined treatment courses.

Onset

Immediate mechanical effect during flushing, with catheter patency supported at the time of use when performed according to local vascular access maintenance protocols.

Browse more Injection & infusion consumable

Top Treatments

Top Cities in the UK